Strongman, Helen; Brown, Adam; Smeeth, Liam; Bhaskaran, Krishnan; (2019) Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals. British journal of cancer. ISSN 0007-0920 DOI: https://doi.org/10.1038/s41416-019-0401-1

Strongman, Helen; Williams, Rachael; Meeraus, Wilhelmine; Murray-Thomas, Tarita; Campbell, Jennifer; Carty, Lucy; Dedman, Daniel; Gallagher, Arlene; Oyinlola, Jessie; Kousoulis, Antonis; +1 more... Valentine, Janet; (2019) Limitations for health research with restricted data collection from UK primary care. Pharmacoepidemiology and drug safety. ISSN 1053-8569 DOI: https://doi.org/10.1002/pds.4765

Chidwick, K; Strongman, H; Matthews, A; Stanway, S; Lyon, AR; Smeeth, L; Bhaskaran, K; (2018) Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink. BMC cancer, 18 (1). p. 1018. ISSN 1471-2407 DOI: https://doi.org/10.1186/s12885-018-4947-8

Matthews, A; Stanway, S; Farmer, RE; Strongman, H; Thomas, S; Lyon, AR; Smeeth, L; Bhaskaran, K; (2018) Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ (Clinical research ed), 363. k3845. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.k3845

Padmanabhan, S; Carty, L; Cameron, E; Ghosh, RE; Williams, R; Strongman, H; (2018) Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. European journal of epidemiology. ISSN 0393-2990 DOI: https://doi.org/10.1007/s10654-018-0442-4

Strongman, H; Christopher, S; Majak, M; Williams, R; Bahmanyar, S; Linder, M; Heintjes, EM; Bennett, D; Korhonen, P; Hoti, F; (2018) Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study. BMJ open diabetes research & care, 6 (1). e000481. ISSN 2052-4897 DOI: https://doi.org/10.1136/bmjdrc-2017-000481

Strongman, H; Kausar, I; Maher, TM; (2018) Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK. Advances in therapy. ISSN 0741-238X DOI: https://doi.org/10.1007/s12325-018-0693-1

Strongman, H; Korhonen, P; Williams, R; Bahmanyar, S; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Linder, M; Dolin, P; +1 more... Heintjes, EM; (2017) Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ open diabetes research & care, 5 (1). e000364. ISSN 2052-4897 DOI: https://doi.org/10.1136/bmjdrc-2016-000364

Korhonen, P; Heintjes, EM; Williams, R; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Strongman, H; Linder, M; Dolin, P; +1 more... Bahmanyar, S; (2016) Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries. BMJ (Clinical research ed), 354. i3903. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.i3903

Strongman, H; D'Oca, K; Langerman, H; Das, R; (2015) Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes, obesity & metabolism, 17 (6). pp. 573-80. ISSN 1462-8902 DOI: https://doi.org/10.1111/dom.12458 Full text not available from this repository.

Das, R; Langerman, H; D'Oca, K; Strongman, H; (2014) An Observational Cohort Study of Diabetes-Associated Secondary Health Care Utilisation in Patients With Type 2 Diabetes Prescribed Dual Combination Therapy With Oral Anti-Hyperglycaemic Agents in the UK. Value in health, 17 (7). A360. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2014.08.782 Full text not available from this repository.